We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
AUM
$255M
AUM Growth
+$98.4M
Cap. Flow
+$101M
Cap. Flow %
39.81%
Top 10 Hldgs %
65.11%
Holding
28
New
4
Increased
17
Reduced
2
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 95.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFLY icon
26
Butterfly Network
BFLY
$2.5B
-114,100
Closed -$2.26M
ILMN icon
27
Illumina
ILMN
$29.1B
-16,140
Closed -$5.81M
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
-42,929
Closed -$6.71M

Similar funds

Eagle Health Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Eagle Health Investments held 28 positions worth $255M, up 63% from $156M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eagle Health Investments deployed $101M of net new capital in Q1 2021, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Inspire Medical Systems: 37,453 shares worth $7.75M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $1.86M trimmed.

  • Eagle Health Investments's largest Q1 2021 buy was Inspire Medical Systems: 37,453 shares worth $7.75M.
  • Eagle Health Investments added most to Agios Pharmaceuticals in Q1 2021, an estimated $14.1M increase.
  • Eagle Health Investments's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $1.86M.
  • Eagle Health Investments fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $6.71M.
  • Eagle Health Investments's ten largest holdings make up 65% of its $255M portfolio in Q1 2021.
  • Eagle Health Investments opened 4 new positions and closed 3 in Q1 2021.
  • Eagle Health Investments's portfolio value rose 63% quarter-over-quarter to $255M.

Based on Eagle Health Investments's 13F filing for Q1 2021, filed 23 Apr 2021.